Granzyme M Cleaves von Willebrand Factor and Affects Its Binding to Factor VIII
Author Information
Author(s): Hollestelle Martine J., Lai Ka Wai, van Deuren Marcel, Lenting Peter J., de Groot Philip G., Sprong Tom, Bovenschen Niels
Primary Institution: University Medical Center Utrecht
Hypothesis
Granzyme M cleaves von Willebrand factor (VWF) and affects its interaction with factor VIII (FVIII).
Conclusion
Granzyme M cleaves VWF, disrupting its ability to bind FVIII, which may have implications in blood coagulation during meningococcal septic shock.
Supporting Evidence
- Granzyme M cleaved both denatured and soluble plasma-derived VWF.
- Granzyme M did not affect the multimeric size of VWF.
- Increased plasma GrM levels correlated with an increased plasma VWF/FVIII ratio in meningococcal sepsis patients.
- Granzyme M destroyed the binding of VWF to FVIII in vitro.
Takeaway
Granzyme M is a protein that can cut another protein called von Willebrand factor, which helps blood clot. When Granzyme M cuts it, von Willebrand factor can't hold onto factor VIII, which is important for stopping bleeding.
Methodology
The study involved in vitro experiments to assess the cleavage of VWF by Granzyme M and its effects on VWF's binding to FVIII, using various assays including immunoblotting and ELISA.
Limitations
The study's findings are based on in vitro experiments and may not fully represent in vivo conditions.
Participant Demographics
Patients with meningococcal disease, including those with septic shock.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website